Skyrizi is a prescription medication used to treat plaque psoriasis, psoriatic arthritis, and Crohn’s disease. It works by targeting specific proteins in the body involved in inflammation. Skyrizi is a brand-name drug containing the active ingredient risankizumab-rzaa, a monoclonal antibody. The average retail price of Skyrizi is $14,052.39 for 1, 10ml of 600mg/10ml vial. However, with a SingleCare Skyrizi coupon, you could reduce this cost, potentially to as low as $9,833.91 for 1, 10ml of 600mg/10ml vial at participating pharmacies.
Edit your dosage
1 box, 1.2ml of 180mg/1.2mlEditar
Desbloquea precios únicos para miembros.Regístrate gratis.
You have 0.00 in available bonus savings. Bonus savings will be automatically applied to your next eligible prescription fill.
Save an extra $3 on any eligible prescription! Sign up for free
Members can save even more
and it's free to join
Los precios de los medicamentos recetados de SingleCare se basan en diversas fuentes. Los precios que publicamos son nuestra mejor estimación, pero no podemos garantizar que el precio que mostramos coincida exactamente con el precio que recibes en la farmacia. Para saber el precio exacto, por favor, comunícate con tu farmacia y proporciona los números BIN/GRP/PCN que aparecen en tu tarjeta de SingleCare.
Cualquier bono de ahorro de Single Care, incluyendo el bono de $3 de inscripción, puede usarse solo (or solamente) una vez.
Precios actualizados: 05/12/2025
Los miembros ahorran más
Skyrizi is a prescription medication used to treat plaque psoriasis, psoriatic arthritis, and Crohn’s disease. It works by targeting specific proteins in the body involved in inflammation. Skyrizi is a brand-name drug containing the active ingredient risankizumab-rzaa, a monoclonal antibody. The average retail price of Skyrizi is $14,052.39 for 1, 10ml of 600mg/10ml vial. However, with a SingleCare Skyrizi coupon, you could reduce this cost, potentially to as low as $9,833.91 for 1, 10ml of 600mg/10ml vial at participating pharmacies.
Skyrizi is a prescription medication used to treat plaque psoriasis, psoriatic arthritis, and Crohn’s disease. It works by targeting specific proteins in the body involved in inflammation. Skyrizi is a brand-name drug containing the active ingredient risankizumab-rzaa, a monoclonal antibody. The average retail price of Skyrizi is $14,052.39 for 1, 10ml of 600mg/10ml vial. However, with a SingleCare Skyrizi coupon, you could reduce this cost, potentially to as low as $9,833.91 for 1, 10ml of 600mg/10ml vial at participating pharmacies.
The cost of Skyrizi is generally higher than other drugs, at an average retail price of around $14,052.39 for 1, 10ml of 600mg/10ml vial. Retail prices can vary based on different factors like pharmacy location and prescribed quantity. With a SingleCare coupon, you might find Skyrizi at a lower price, potentially around $9,833.91 for 1, 10ml of 600mg/10ml vial.
The cost of Skyrizi with insurance depends on your plan's coverage, prescribed quantity, and other factors. Insurance may help cover a portion of the cost, but copays or coinsurance may still apply. It's recommended to check with your insurance provider and compare it with SingleCare's discounted price for the best deal.
Medicare coverage for Skyrizi varies based on the plan, prescription details, and coverage stage. Contact your Medicare insurance plan’s provider for more information on the cost of Skyrizi. For those without Medicare, a SingleCare Skyrizi coupon may be a potential savings option. A SingleCare Skyrizi coupon may help lower the price to $9,833.91 for 1, 10ml of 600mg/10ml vial at participating pharmacies.
Skyrizi is currently available as a brand-name drug only. There is no generic version available at this time.
Skyrizi is a prescription drug that helps treat severe cases of plaque psoriasis, psoriatic arthritis, and Crohn’s disease, which are conditions linked to an overactive immune response. The active ingredient in Skyrizi, risankizumab-rzaa, works by targeting interleukin-23 (IL-23), a key protein involved in inflammation in the immune system. As a result, Skyrizi can help alleviate symptoms of certain inflammatory conditions.
Skyrizi is available as a subcutaneous (under the skin) or intravenous (into the vein) injection. The subcutaneous injections come as a single-dose prefilled pen, syringe, or cartridge in strengths of 75 mg/0.83 mL to 360 mg/2.4 mL. The intravenous injection comes as a 600 mg/10 mL single-dose vial. The dosage of Skyrizi depends on the condition being treated. However, it’s typically given periodically every eight or 12 weeks. Always consult a healthcare provider for appropriate dosage instructions.
Skyrizi may cause side effects. The most common side effects of Skyrizi include:
Injection site reactions
Upper respiratory infections
Headache
Joint pain
Stomach pain
Low red blood cells (anemia)
Back pain
Fever
Fatigue
Urinary tract infections
Skyrizi is not typically associated with hair loss or weight changes. However, it may carry a risk of serious side effects, such as severe allergic reactions, liver problems, and an increased risk of infections. Seek immediate medical attention if you experience signs or symptoms of an allergic reaction, such as hives, swelling of the face or throat, or trouble breathing. Consult a healthcare provider for other potential side effects, drug interactions, and warnings.
Skyrizi has been associated with potential liver problems, although such cases are relatively rare and generally linked to the starting phases of treatment. Healthcare providers may recommend regular liver blood tests when using Skyrizi, especially for those with a history of liver issues. Any symptoms of liver problems, such as yellowing of the skin or eyes, should be reported to a healthcare provider immediately.
Determining whether Skyrizi or Humira is better depends on the person’s medical condition, history, and response to treatment. Both medications are used to treat conditions like psoriatic arthritis and plaque psoriasis, but they work in slightly different ways. Skyrizi targets interleukin-23 (IL-23), while Humira targets tumor necrosis factor (TNF). Consult a healthcare provider to determine the most appropriate treatment option.
The onset of action for Skyrizi can vary from person to person. Some people may start seeing improvements in their symptoms within four weeks of starting treatment, while for others, it may take over four months. In any case, the full benefits of Skyrizi might not be seen until several months into treatment. Regular visits with a healthcare provider are recommended to monitor the effectiveness of the treatment and make adjustments as needed.
Gerardo Sison, Pharm.D., graduated from the University of Florida. He has worked in both community and hospital settings, providing drug information and medication therapy management services. As a medical writer, he hopes to educate and empower patients to better manage their health and navigate their treatment plans.
...SingleCare se acepta en la mayoría de las farmacias y supermercados del país, incluyendo los siguientes:
Los ahorros en recetas varían según la receta médica y la farmacia, y pueden alcanzar hasta un 80% de descuento sobre el precio en efectivo. Este es un plan de descuento de recetas médicas. NO es un seguro ni un plan de medicamentos de Medicare. El rango de descuentos para las recetas médicas que se brindan bajo este plan, dependerá de la receta y la farmacia donde se adquiera la receta y puede otorgarse hasta un 80% de descuento sobre el precio en efectivo. Usted es el único responsable de pagar sus recetas en la farmacia autorizada al momento que reciba el servicio, sin embargo, tendrá el derecho a un descuento por parte de la farmacia de acuerdo con el Programa de Tarifas de Descuento que negoció previamente. Towers Administrators LLC (que opera como “SingleCare Administrators”) es la organización autorizada del plan de descuento de recetas médicas ubicada en 4510 Cox Road, Suite 11, Glen Allen, VA 23060. SingleCare Services LLC (“SingleCare”) es la comercializadora del plan de descuento de prescripciones médicas que incluye su sitio web www.singlecare.com. Como información adicional se incluye una lista actualizada de farmacias participantes, así como también asistencia para cualquier problema relacionado con este plan de descuento de prescripciones médicas, comunícate de forma gratuita con el Servicio de Atención al Cliente al 844-234-3057, las 24 horas, los 7 días de la semana (excepto los días festivos). Al utilizar la aplicación o la tarjeta de descuento para recetas médicas de SingleCare acepta todos los Términos y Condiciones, para más información visita: https://www.singlecare.com/es/terminos-y-condiciones. Los nombres, logotipos, marcas y otras marcas comerciales de las farmacias son propiedad exclusiva de sus respectivos dueños.
Los artículos del blog no constituyen asesoramiento médico. Su propósito es brindar información general y no sustituyen el asesoramiento, diagnóstico ni tratamiento médico profesional. Si tiene alguna pregunta sobre una afección médica, consulte siempre a su médico u otro profesional de la salud cualificado. Si cree tener una emergencia médica, llame inmediatamente a su médico o al 911.
© 2025 SingleCare Administrators. Todos los derechos reservados
© 2025 SingleCare Administrators. Todos los derechos reservados